Shopping Cart
- Remove All
- Your shopping cart is currently empty
KDM2A/7A-IN-1 is a cell-permeable and selective inhibitor of histone lysine demethylase KDM2A/7A, with potential antitumor activity for studying duodenal adenomas and ossifying fibromucoid tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $272 | In Stock | |
5 mg | $662 | In Stock | |
10 mg | $1,060 | In Stock | |
25 mg | $2,090 | In Stock | |
50 mg | $2,780 | In Stock | |
100 mg | $3,700 | In Stock |
Description | KDM2A/7A-IN-1 is a cell-permeable and selective inhibitor of histone lysine demethylase KDM2A/7A, with potential antitumor activity for studying duodenal adenomas and ossifying fibromucoid tumors. |
Targets&IC50 | KDM2A:0.16 μM |
In vitro | KDM2A/7A-IN-1 is a highly cell-permeable inhibitor of KDM2A/7A, with an IC50 of 0.16 μM. KDM2A/7A-IN-1 (0.4, 3.1, 6.2 μM) increases the level of H3K36me2 in HeLa cells with ectopic expression of catalytically active KDM2A[1]. |
Molecular Weight | 506.68 |
Formula | C33H38N4O |
Cas No. | 2169272-46-0 |
Smiles | CC(=O)N1[C@@H](c2cncc(CCCCCCCN3CCCC3)c2)[C@@](C#N)(c2ccccc12)c1ccccc1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 120 mg/mL (236.84 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.